Vyant Bio Inc (VYNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 3,222 | 1,512 | 1,430 | 1,855 | 1,705 |
| Cost of Goods | 2,566 | 1,503 | 1,290 | 1,364 | 1,211 |
| Gross Profit | 656 | 9 | 140 | 490 | 494 |
| Operating Expenses | 6,131 | 4,923 | 4,367 | 3,593 | 2,385 |
| Operating Income | -4,909 | -4,411 | -3,937 | -2,739 | -1,680 |
| Interest Expense | 36 | 31 | 341 | 348 | 356 |
| Other Income | 148 | 255 | -22 | 562 | -1,030 |
| Pre-tax Income | -4,797 | -4,187 | -4,300 | -2,525 | -3,066 |
| Income Tax | N/A | N/A | -1,814 | 0 | N/A |
| Net Income Continuous | -4,797 | -4,187 | -2,486 | -2,525 | -3,066 |
| Net Income | $-4,797 | $-4,187 | $-2,486 | $-2,525 | $-3,066 |
| EPS Basic Total Ops | -75.08 | -67.57 | -40.54 | -225.23 | -91.59 |
| EPS Basic Continuous Ops | -75.22 | -67.57 | -40.23 | -225.33 | -91.06 |
| EPS Diluted Total Ops | -76.58 | -70.57 | -40.54 | 216.22 | -91.59 |
| EPS Diluted Continuous Ops | -75.22 | -67.46 | -40.23 | -224.39 | -91.06 |
| EBITDA(a) | $-4,629 | $-4,287 | $-3,523 | $-2,341 | $-1,328 |